Cannabis Clashes with Legal Storms and Operational Shifts

Cannabis Clashes with Legal Storms and Operational Shifts

Author: Cannabis Radio August 26, 2026 Duration: 10:11

The federal government’s increasing acknowledgment of medical cannabis applications marks a pivotal turning point for the sector, granting long-sought validation to consumers and patients alike.

However, this formal legitimacy comes with heightened accountability, obligating operators to raise their standards around clinical credibility, operational transparency, and rigorous patient education.At the same time, the broader market remains caught in a turbulent regulatory transition.

While rescheduling initiatives offer a potential path forward, businesses and their legal advisors continue to navigate persistent banking bottlenecks, restricted capital access, and compounding risks of insolvency and financial distress.

Compounding these structural hurdles, major multi-state operators—including Cresco Labs, Green Thumb Industries, Curaleaf, and Verano—now face a severe wave of legal exposure. Beset by sweeping federal class actions, civil RICO claims targeting therapeutic marketing practices, and mounting insurance coverage disputes, the commercial cannabis industry is navigating an increasingly complex legal and financial battlefield.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 50

Blunt Business
Podcast Episodes
The Ongoing Federal Rescheduling and Operational Hurdles in Cannabis [not-audio_url] [/not-audio_url]

Duration: 25:22
Blunt Business welcomes Joe Bayern, the CEO of MM Brands to discuss how the cannabis industry is approaching a potential turning point as DOJ and DEA hearings conclude this July, with anticipation high for a move to Sche…
Banking, Compliance, and the DOJ Hearing for Cannabis Rescheduling [not-audio_url] [/not-audio_url]

Duration: 29:09
Once again we welcome back Nick Richards, Partner and co-chair of the cannabis law practice group at Greenspoon Marder about how the cannabis and hemp industries currently face a complex landscape defined by existential…
Clarifying Cannabis From THCA Loopholes to Schedule III Shifts [not-audio_url] [/not-audio_url]

Duration: 40:52
Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors. She clarifies the critical distinction between THC…
Kazmira Therapeutics and the Future of CBD Medicine [not-audio_url] [/not-audio_url]

Duration: 28:24
Kazmira Therapeutics is revolutionizing the CBD landscape by transitioning cannabinoids from over-the-counter health supplements to precision, pharmacist-compounded "real medicine". Led by co-founders Dr. Priyanka Sharma…
Georgia Expands Medical Access and D.C. Beats Cannabis Lawsuit [not-audio_url] [/not-audio_url]

Duration: 18:51
This week on Blunt Business, we’re diving into two massive legal shifts reshaping cannabis markets on opposite sides of the country. First, we break down Georgia’s major policy overhaul as Governor Brian Kemp signs the "…
$15 Billion Refund? Navigating Retroactive 280E Relief [not-audio_url] [/not-audio_url]

Duration: 24:46
As the federal government moves toward rescheduling marijuana, the cannabis industry is eyeing a massive financial shift: the potential for $15 billion in retroactive tax relief from Section 280E. While the transition to…